0001813688-26-000003.txt : 20260911 0001813688-26-000003.hdr.sgml : 20260911 20260911114413 ACCESSION NUMBER: 0001813688-26-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260911 DATE AS OF CHANGE: 20260911 EFFECTIVENESS DATE: 20260911 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tempo Therapeutics, Inc. CENTRAL INDEX KEY: 0001813688 ORGANIZATION NAME: EIN: 472320475 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-597176 FILM NUMBER: 261373281 BUSINESS ADDRESS: STREET 1: 3030 BUNKER HILL STREET STREET 2: SUITE 104 CITY: SAN DIEGO STATE: CA ZIP: 92109 BUSINESS PHONE: (251) 654-4070 MAIL ADDRESS: STREET 1: 3030 BUNKER HILL STREET STREET 2: SUITE 104 CITY: SAN DIEGO STATE: CA ZIP: 92109 D 1 primary_doc.xml X0708 D LIVE 0001813688 Tempo Therapeutics, Inc. 3030 BUNKER HILL STREET Suite 308 SAN DIEGO CA CALIFORNIA 92109 6192027445 DELAWARE None None Corporation true Westbrook Weaver 3030 BUNKER HILL STREET Suite 308 SAN DIEGO CA CALIFORNIA 92109 Executive Officer Director Donald Griffin 3030 BUNKER HILL STREET Suite 308 SAN DIEGO CA CALIFORNIA 92109 Director Biren Mehta 3030 BUNKER HILL STREET Suite 308 SAN DIEGO CA CALIFORNIA 92109 Director Steven Sands 3030 BUNKER HILL STREET Suite 308 SAN DIEGO CA CALIFORNIA 92109 Director Eric Richman 3030 BUNKER HILL STREET Suite 308 San Diego CA CALIFORNIA 92109 Executive Officer Director Biotechnology Decline to Disclose 06b false 2026-08-27 false true false 0 14500000 14000000 500000 false 43 0 0 0 false Tempo Therapeutics, Inc. /s/ Eric Richman Eric Richman Chief Executive Officer 2026-09-11